These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Boronated antibodies for neutron capture therapy. Abraham R; Müller R; Gabel D Strahlenther Onkol; 1989; 165(2-3):148-51. PubMed ID: 2494718 [No Abstract] [Full Text] [Related]
5. Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia. Tamat SR; Patwardhan A; Moore DE; Kabral A; Bradstock K; Hersey P; Allen BJ Strahlenther Onkol; 1989; 165(2-3):145-7. PubMed ID: 2494717 [No Abstract] [Full Text] [Related]
6. Conjugation, purification and characterization of boronated monoclonal antibodies for use in neutron capture therapy. Barth RF; Mafune N; Alam F; Adams DM; Soloway AH; Makroglou GE; Oredipe OA; Blue TE; Steplewski Z Strahlenther Onkol; 1989; 165(2-3):142-5. PubMed ID: 2494716 [No Abstract] [Full Text] [Related]
7. Integrated approach in the planning of neutron capture therapy. Ryabukhin YS Strahlenther Onkol; 1989; 165(2-3):158-62. PubMed ID: 2494721 [No Abstract] [Full Text] [Related]
8. First human clinical trial of melanoma neutron capture. Diagnosis and therapy. Mishima Y; Ichihashi M; Hatta S; Honda C; Yamamura K; Nakagawa T; Obara H; Shirakawa J; Hiratsuka J; Taniyama K Strahlenther Onkol; 1989; 165(2-3):251-4. PubMed ID: 2494743 [No Abstract] [Full Text] [Related]
9. Fast neutrons from the Essen cyclotron can be used successfully for neutron capture experiments in vitro. Ziegler W; Sauerwein W; Streffer C Strahlenther Onkol; 1989; 165(2-3):210-2. PubMed ID: 2494731 [No Abstract] [Full Text] [Related]
10. Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy. Mill AJ Strahlenther Onkol; 1989; 165(2-3):193-6. PubMed ID: 2494726 [No Abstract] [Full Text] [Related]
11. Boron determination for neutron capture therapy by colorimetry and emission spectrometry. Strouf O; Mertenová E; Schneiderová L; Zámecníková H; Janků I Strahlenther Onkol; 1989; 165(2-3):174-6. PubMed ID: 2494723 [No Abstract] [Full Text] [Related]
12. Method of in situ dosimetry in boron neutron capture therapy. Blue J; Roberts W; Blue T; Wang C Strahlenther Onkol; 1989; 165(2-3):109-12. PubMed ID: 2494710 [No Abstract] [Full Text] [Related]
13. Fractionation and other clinical considerations in boron neutron capture therapy. Durrant KR; Hopewell JW Strahlenther Onkol; 1989; 165(2-3):231-3. PubMed ID: 2494739 [No Abstract] [Full Text] [Related]
14. Dose bracketing in boron neutron capture therapy. Gahbauer R; Kanellitsas C; Blue T; Wang C; Clendenon N; Fairchild R; Laster B; McGregor J; Goodman J Strahlenther Onkol; 1989; 165(2-3):229-30. PubMed ID: 2494738 [No Abstract] [Full Text] [Related]
15. Optimization of fast neutron spectra available for neutron capture therapy. Pfister G; Hehn G; el-Husseini F Strahlenther Onkol; 1989; 165(2-3):107-9. PubMed ID: 2494709 [No Abstract] [Full Text] [Related]
16. A design study of an accelerator-based epithermal neutron source for boron neutron capture therapy. Wang CK; Blue TE; Gahbauer RA Strahlenther Onkol; 1989; 165(2-3):75-8. PubMed ID: 2494748 [No Abstract] [Full Text] [Related]
17. Neutron capture therapy with gadolinium-157. Allen BJ; McGregor BJ; Martin RF Strahlenther Onkol; 1989; 165(2-3):156-8. PubMed ID: 2494720 [No Abstract] [Full Text] [Related]
18. Reactor moderated intermediate energy neutron beams for neutron capture therapy. Less TJ; Brugger RM Strahlenther Onkol; 1989; 165(2-3):87-90. PubMed ID: 2494752 [No Abstract] [Full Text] [Related]
19. RBE of thermal neutron capture therapy using 10B1-para-boronophenylalanine for human and B-16 melanoma cells. Ichihashi M; Sasase A; Hiramoto T; Mishima Y; Fukuda H; Kobayashi T Strahlenther Onkol; 1989; 165(2-3):198-201. PubMed ID: 2494727 [No Abstract] [Full Text] [Related]